Empowering Tennessee Pharmacists to Initiate PrEP Using Collaborative Pharmacy Practice Agreements

Author:

Cernasev Alina1,Barenie Rachel E.1,Wofford Breanne R.1,Golden Jay2ORCID,Walker Crystal3

Affiliation:

1. Department of Clinical Pharmacy and Translational Science, University of Tennessee Health Science Center College of Pharmacy, Nashville, TN 37211, USA

2. Specialty Pharmacy, Walgreens Company, Nashville, TN 37203, USA

3. College of Nursing, University of Tennessee Health Science Center College of Nursing, Memphis, TN 38168, USA

Abstract

Background: The uptake of Pre-Exposure Prophylaxis (PrEP) has revolutionized the fight against the Human Immunodeficiency Virus (HIV) epidemic. Consistent obstacles remain that have influenced the slow uptake of PrEP in the United States of America (USA). In order to address these barriers, pharmacists must be included in the dispensing and management of PrEP through collaborative pharmacy practice agreements (CPPAs). Our aim for this study was to characterize pharmacists’ perceptions of initiating PrEP through a CPPA in the state of Tennessee. Methods: This qualitative study was conducted in the USA in 2021 with pharmacists practicing in Tennessee. A framework and specific questions guided the thematic analysis. The words and phrases were coded inductively and later collapsed into categories and placed into emergent themes. Results: Two themes illustrate the voices of practicing pharmacists’ integration in the dispensing and management of PrEP: (1) Learning from other states and previous successful CPPAs to advance and expand innovative models of patient care and (2) advocacy through public policy change to empower pharmacists to initiate PrEP. Conclusion: This qualitative study focused on exploring pharmacists’ perceptions on the opportunity of initiating PrEP through a CPPA in Tennessee. These findings highlight the preparedness of pharmacists to advocate for easier initiative of PrEP in pharmacies across Tennessee, whether through relaxing existing CPPA regulation or pursuing independent prescriptive authority for pharmacists.

Publisher

MDPI AG

Subject

General Computer Science

Reference31 articles.

1. Center for Disease Control (2022, August 08). HIV Basic Statistics, Available online: https://www.cdc.gov/hiv/basics/statistics.html.

2. World Health Organization (2022, August 08). HIV. Available online: https://www.who.int/data/gho/data/themes/hiv-aids.

3. Department of Health and Human Services (2022, August 08). Pre-Exposure Prophylaxis, Available online: https://www.hiv.gov/hiv-basics/hiv-prevention/using-hiv-medication-to-reduce-risk/pre-exposure-prophylaxis.

4. Center for Disease Control (2022, August 08). What Is PrEP?, Available online: https://www.cdc.gov/hiv/basics/prep/about-prep.html.

5. Center for Disease Control (2022, August 08). PrEP Effectiveness, Available online: https://www.cdc.gov/hiv/basics/prep/prep-effectiveness.html.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3